Results 231 to 240 of about 653,368 (363)
A novel ELF4 gene variant disrupts T and NK cell function in a patient with immune thrombocytopenia (ITP). [PDF]
Kendirli PK +9 more
europepmc +1 more source
Generation of CCR4/CD7 Bispecific CAR‐T Cells Resistant to Fratricide and Exhaustion
The applications of CAR T‐cell therapy in T‐cell malignancies face limitations such as fratricide, effector‐cell exhaustion, and antigen‐escape. Herein, we developed fratricide‐ and exhaustion‐resistant CAR‐T cells that targeted CCR4 and CD7 simultaneously, with optional EGFRt safety switch. Additionally, scRNA‐seq unveiled new molecular targets, which
Sile Li +10 more
wiley +1 more source
Primary NK/T Cell Lymphoma of the Upper Esophagus
Sho Morita, Atsuro Seki, Noboru Hamada
openalex +2 more sources
iPSC-derived Rejuvenated T-cell Therapy for Extranodal NK/T-cell Lymphoma, Nasal Type
Miki Ando +5 more
openalex +2 more sources
Functional segregation of HIF-1α and AhR controls NK cell responsiveness under hypoxia. [PDF]
Giorgetta S +9 more
europepmc +1 more source
The inhibitory immune checkpoints HLA‐G and CD47 are expressed on certain tumor types and inhibit immune cells in the tumor microenvironment. DSP216 binds specifically to cancer cells expressing both HLA‐G and CD47, and blocks their inhibitory signaling.
Lisa J. Jacob +12 more
wiley +1 more source
NK cell adoptive transfer in acute myeloid leukemia: a systematic review and meta-analysis. [PDF]
Grassi LDV +11 more
europepmc +1 more source
Hepatocellular carcinoma (HCC)‐derived extracellular vesicles (EVs) enrich the metabolic enzyme ATP‐citrate lyase (ACLY). EV‐transferred ACLY enhances palmitate biosynthesis, increases the S‐palmitoylation and stability of multiple immune checkpoint proteins, augments the cellular immunosuppressive activity, and ultimately accelerates the malignant ...
Zhijun Liu +11 more
wiley +1 more source
Circulating and Tumor-Infiltrating Foxp3+ Regulatory T Cell Subset in Chinese Patients with Extranodal NK/T Cell Lymphoma [PDF]
Roujun Peng +7 more
openalex +1 more source

